| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 185.43B | 179.82B | 185.11B | 183.59B | 160.74B | 151.55B |
| Gross Profit | 16.27B | 17.48B | 14.86B | 11.93B | 11.97B | 15.11B |
| EBITDA | 5.76B | 6.69B | 6.79B | 7.55B | 4.84B | 7.32B |
| Net Income | 2.63B | 5.03B | 3.43B | 4.26B | 2.36B | 4.71B |
Balance Sheet | ||||||
| Total Assets | 241.01B | 255.91B | 225.10B | 211.27B | 183.40B | 173.08B |
| Cash, Cash Equivalents and Short-Term Investments | 16.93B | 24.77B | 16.53B | 18.61B | 17.19B | 19.30B |
| Total Debt | 82.25B | 75.68B | 56.00B | 34.33B | 30.10B | 29.05B |
| Total Liabilities | 169.53B | 177.16B | 154.98B | 139.14B | 117.85B | 109.14B |
| Stockholders Equity | 71.15B | 78.42B | 69.81B | 71.83B | 65.08B | 63.47B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -14.39B | -20.77B | -4.29B | -721.00M | 5.12B |
| Operating Cash Flow | 0.00 | -13.89B | -20.29B | 3.97B | -219.00M | 5.27B |
| Investing Cash Flow | 0.00 | 3.83B | 615.00M | -4.29B | -2.49B | -810.00M |
| Financing Cash Flow | 0.00 | 18.01B | 17.93B | 1.15B | 580.00M | -3.43B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥76.63B | 11.31 | ― | 1.25% | 4.37% | 6.30% | |
69 Neutral | ¥66.11B | 11.09 | ― | 3.55% | 3.44% | 5.35% | |
68 Neutral | ¥75.95B | 20.42 | ― | 8.02% | -4.15% | -16.83% | |
66 Neutral | ¥66.30B | 14.37 | ― | 3.84% | -2.49% | 23.25% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥65.11B | 12.65 | ― | 3.64% | 4.96% | 17.55% | |
58 Neutral | ¥69.85B | 12.71 | ― | 2.73% | -2.86% | 50.42% |